Kohmann Bosshard Financial Services LLC Takes Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Kohmann Bosshard Financial Services LLC acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 317 shares of the exchange traded fund’s stock, valued at approximately $29,000.

Several other institutional investors have also recently modified their holdings of the company. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after purchasing an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd purchased a new stake in SPDR S&P Biotech ETF during the 3rd quarter valued at about $141,284,000. Proficio Capital Partners LLC boosted its holdings in SPDR S&P Biotech ETF by 16,156.1% during the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock valued at $82,615,000 after acquiring an additional 911,686 shares during the period. Mirae Asset Securities USA Inc. boosted its holdings in SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after acquiring an additional 300,000 shares during the period. Finally, Assetmark Inc. boosted its holdings in SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after acquiring an additional 588,489 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $85.60 on Tuesday. The stock has a market capitalization of $5.65 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The business has a 50-day moving average of $90.88 and a 200 day moving average of $95.66.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.